#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma Haemophilia A with anti factor VIII Candida infection Chronic lymphocytic leukaemia Oropharyngeal cancer recurrent Small for dates baby Crigler-Najjar syndrome Plasma cell myeloma refractory Arginase deficiency Autoimmune disorder Chronic graft versus host disease in intestine Cervix carcinoma recurrent Acute respiratory distress syndrome Small cell lung cancer Familial haemophagocytic lymphohistiocytosis More trials…

    Learn about Rare Diseases

    Choroid melanoma – Treatment Congenital nephrogenic diabetes insipidus Lennox-Gastaut syndrome – Life with Disease Pituitary-dependent Cushing’s syndrome – Diagnostics Mast cell activation syndrome – Basic Information Haemophagocytic lymphohistiocytosis – Trials in Disease Nodal marginal zone B-cell lymphoma – Basic Information Amyotrophic lateral sclerosis – Trials in Disease Mastocytosis – Basic Information Immunodeficiency congenital – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Levofolinate ANUMIGILIMAB Netupitant L-PROLINE Pomalidomide Sodium Phenylbutyrate ALE.P03 Fluoroethyltyrosine F-18 Transpocart19 204-NETU Calcium Human Coagulation Factor Ii Arbaclofen Dexmedetomidine PROMESTRIENE Sirexatamab Fluindione Andexanet Alfa Bexmarilimab Betula Verrucosa Pollen More therapies…

    Learn about Your Condition

    Hepatoblastoma Androgenetic alopecia Impaired gastric emptying Lymphangioma Renal cell carcinoma stage IV Hypophosphatasia Biliary tract disorder Cachexia Laryngeal leukoplakia Palmoplantar pustulosis Rett syndrome COVID-19 Fibrous dysplasia of bone Osteoporosis CDKL5 deficiency disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2pn Bullwldwh Ds Sqmfzw Mjmxwybkqja Bo 1mgg Mtmsuoimgx 1lqejb Fwmtkc

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer recurrent
    • Oesophageal carcinoma
    • Gastric cancer
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    France

  • Study of Paclitaxel, Carboplatin, and Bevacizumab with Niraparib for Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer After Surgery

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Niraparib
    • Niraparib Tosilate Monohydrate
    Belgium France Italy Spain

  • Study on Enhanced GVH Prevention in Elderly Patients with Blood Cancer Using Rabbit Anti-Human Thymocyte Immunoglobulin During Stem Cell Transplantation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Haematological malignancy
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    France

  • Study on the Effectiveness of Doxorubicin, Ifosfamide, and Dacarbazine in High-Risk Soft Tissue Sarcoma Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dacarbazine Citrate
    • Doxorubicin
    • Ifosfamide
    France

  • Study of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Lenalidomide
    • Teclistamab
    Austria Belgium Czechia Denmark France Germany +7

  • Study on Mifamurtide with Chemotherapy for Patients with High-Risk Osteosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma metastatic
    • Osteosarcoma
    Investigated Drugs:
    • Mifamurtide
    • Ifosfamide
    • Cisplatin
    France

  • Study on the Long-Term Safety of Futibatinib and Fulvestrant for Patients with Malignant Solid Tumors

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Futibatinib
    • Fulvestrant
    France Portugal Spain Sweden

  • Study on BI 764532 for Patients with Relapsed or Refractory Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    • Small cell lung cancer
    Investigated Drugs:
    • Bi 764532
    • Igg-Like T Cell Engager Binding To Dll3 And Cd3
    Belgium Bulgaria France Germany Italy Poland +2

  • Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    • Treosulfan
    Belgium France

  • Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Odronextamab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Austria Belgium Czechia France Germany Italy +2
Previous Page
1 … 12 13 14 15 16 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!